| Patents for A61P 17 - Drugs for dermatological disorders (106,455) |
|---|
| 07/29/2004 | US20040147788 Stilbene derivatives and their use as aryl hydrocarbon receptor antagonistic ligands |
| 07/29/2004 | US20040147754 Novel process |
| 07/29/2004 | US20040147745 Novel compounds and compositions as protease inhibitors |
| 07/29/2004 | US20040147741 Heptadecapeptide nociceptin opioid receptor modulators; pain relievers; synthesis |
| 07/29/2004 | US20040147724 for diagnosis/treatment of cancer, myeloproliferative disorders, angiogenesis, obesity, osteoporosis, non-insulin dependent diabetes, lipid metabolism disorder, hypercalcemia, hypercholestrolemia; genetic engineering |
| 07/29/2004 | US20040147599 Medium-chain length fatty acids, glycerides and analogues as neutrophil survival and activation factors |
| 07/29/2004 | US20040147587 Compounds for the modulation of the glycolysis enzyme and/or transaminase complex |
| 07/29/2004 | US20040147586 Antiproliferative agents; anticancer agents; glioblastomas; antidiabetic agents; autoimmune disorders; skin disorders; antiarthritic agents; antiinflammatory agents; cardiovascular disorders |
| 07/29/2004 | US20040147578 Use of lipoaminoacids as absorption promoters in a pharmaceutical composition |
| 07/29/2004 | US20040147573 Metalloproteinase inhibitors |
| 07/29/2004 | US20040147562 Controlling cell gene expression; moderate cell proliferation; anticancer agents; antiinflammatory agents; cardiovascular disorders; autoimmune disease |
| 07/29/2004 | US20040147558 Synthesis of 3-amino-thalidomide and its enantiomers |
| 07/29/2004 | US20040147551 Competitive binding to estrogen; prevent mnopause syndrome ; anxiolytic agents; antidepressants; benign prostatic hyperplasia; anticancer agents; inflammatory bowel disorders; antiarthritic agents |
| 07/29/2004 | US20040147525 Antiinflammatory agents; analgesics; antiarthritic agents |
| 07/29/2004 | US20040147520 Sulfonylquinoxalone acetamide derivatives and related compounds as bradykinin antagonists |
| 07/29/2004 | US20040147519 Sulfonylquinoxalone acetamide derivatives as bradykinin antagonists |
| 07/29/2004 | US20040147512 Heteroaryl, heterocyclic and aryl compounds which inhibit leukocyte adhesion mediated by VLA-4 |
| 07/29/2004 | US20040147508 Biologically active methylene blue derivatives |
| 07/29/2004 | US20040147506 Muscarinic acetylcholine receptor antagonist; Parkinson's disease; dystonia; analgesics; irritable bowel syndrome |
| 07/29/2004 | US20040147505 Neurodegradative diseases; antiinflammatory agents; analgesics; drug abuse |
| 07/29/2004 | US20040147500 Injectable galenic formulation for use in a diagnosis or a photodynamic therapy and method for preparing same |
| 07/29/2004 | US20040147491 Prevent, maintenance of Dna damage; administering compound which forms nicotinamide-adenine dinucleotide |
| 07/29/2004 | US20040147490 Immunosuppressants |
| 07/29/2004 | US20040147485 Antiinflammatory agents; antiischemic agents; antiarthritic agents; antihistamines; multiple sclerosis; Alzheimer's disease; Huntington's disease; parkinson's disease; antiepileptic agents; headaches |
| 07/29/2004 | US20040147468 Immunostimulatory nucleic acid molecules |
| 07/29/2004 | US20040147449 For inhibition of vascularization and for cancer therapy |
| 07/29/2004 | US20040147430 Using compounds stimulating secretion of insulin, glucosidase inhibitors, thiazolidinediones, insulin, agents enhancing sensitivity to insulin, glucagon-like peptide-1 (GLP-1), PPAR alpha / gamma agonists, meglitinide and aP2 inhibitors |
| 07/29/2004 | US20040147010 Lipoteichoic acid from lactic acid bacteria and its use to modulate immune responses mediated by gram-negative, potential pathogenic gram-positive bacteria |
| 07/29/2004 | US20040146964 Assays, methods and means |
| 07/29/2004 | US20040146888 Cystine-knot polypeptides: cloaked-2 molecules and uses thereof |
| 07/29/2004 | US20040146872 Comprises nucleotide sequences coding delta-2-enoyl-coA isomerase for use in identifying modulators for treatment and diagnosis of inflammatory, cardiovascular, skin, body weight and cancer disorders |
| 07/29/2004 | US20040146555 Useful in the removal of abnormal keratinous material, as is to be observed, for example, in onychomycoses, psoriasis of the nail, or warts |
| 07/29/2004 | US20040146513 Monoclonal antibodies against human protein Mcm3, process for their production, and their use |
| 07/29/2004 | US20040146508 Use of cd25 binding molecules in steroid-resistant patients |
| 07/29/2004 | US20040146477 Cosmetic or pharmaceutical agent |
| 07/29/2004 | DE10301917A1 Use of porphyrin precursors for photodynamic therapy of psoriasis and inflammatory skin and joint diseases |
| 07/29/2004 | CA2516398A1 Method of modulating il-6 |
| 07/28/2004 | EP1440977A1 Improved process for the preparation of diamidic derivatives of the tripeptid KPV |
| 07/28/2004 | EP1440976A1 Modified aminoacids, pharmaceuticals containing these compounds and method for their production |
| 07/28/2004 | EP1440148A2 Keratinocytes which may be used as biologically active substances for the treatment of wounds |
| 07/28/2004 | EP1440083A2 Molecules |
| 07/28/2004 | EP1440073A1 Pde9 inhibitors for treating cardiovascular disorders |
| 07/28/2004 | EP1440062A1 An efficient synthesis of 5-heteroatom-containing-pyrazoles |
| 07/28/2004 | EP1440059A1 3-azabicyclo(3.1.0)hexane derivatives as opioid receptor antagonists |
| 07/28/2004 | EP1439846A2 Storage-stable human fibrinogen solutions |
| 07/28/2004 | EP1439841A2 Androgen receptor modulators and methods of use thereof |
| 07/28/2004 | EP1439838A1 Macrolides containing pharmaceutical compositions |
| 07/28/2004 | EP1439837A1 Pyrazolidinone compounds as ligands of the prostaglandin ep2 and/or ep4 receptors |
| 07/28/2004 | EP1439832A1 Method of treating acne vulgaris using avermectin compound |
| 07/28/2004 | EP1439831A1 Pharmaco-dietary preparation having a nutrition-supplementing and nutrition-enhancing effect |
| 07/28/2004 | EP1439817A1 Composition containing feverfew extract and use thereof |
| 07/28/2004 | EP1372659B1 Substances for use in therapy of diseases that are caused by highly proliferative cells |
| 07/28/2004 | EP1226244B1 Polypeptides with non-natural primary signalling motifs |
| 07/28/2004 | EP1175445B1 Specific antibodies and antibody fragments for tgfbeta1 |
| 07/28/2004 | EP1061802B1 Topical carbamazepine formulations and methods of use |
| 07/28/2004 | EP1058698B1 Preparation for prevention and healing of inflammation affections |
| 07/28/2004 | EP0988040B1 Use of glucosamine and glucosamine derivatives for quick alleviation of itching or localized pain |
| 07/28/2004 | EP0927183B1 Spirocyclic metalloprotease inhibitors |
| 07/28/2004 | EP0912741B1 T-cell selective interleukin-4 agonists |
| 07/28/2004 | EP0823895B1 Fatty acid esters as bioactive compounds |
| 07/28/2004 | EP0735885B1 Ointments comprising mometasone furoate and salicylic acid for the topical treatment of psoriasis |
| 07/28/2004 | EP0696201B1 Supplemented tissue sealants, methods of their production and use |
| 07/28/2004 | CN1516739A Use of HMG fragments as anti-inflammatory agents |
| 07/28/2004 | CN1516701A (Pyrido/thieno)-[f]-oxazepin-5-one derivatives as AMPA receptor positive regulator |
| 07/28/2004 | CN1516700A Substituted 4H-chromenes and analogs as activators ofgasp ases and inducers of apoptosis and use thereof |
| 07/28/2004 | CN1516698A Arylindenopyridines with PDE inhibiting activity |
| 07/28/2004 | CN1516692A Novel compounds of family of 3-alkyl-(4,5-diphenyl-imidazol-1-yl) and their use as soothing agents |
| 07/28/2004 | CN1516690A Heterocyclic derivatives and medicines |
| 07/28/2004 | CN1516687A 3,4-di-substituted cyclobutene-1,2-diones as CXC-chemokine receptor ligands |
| 07/28/2004 | CN1516593A A topical anti-itchu formulation and process for preparation thereof |
| 07/28/2004 | CN1516592A Krill and/or marine extracts for prevention and/or treatment of cardiovascular diseases, arthritis, skin cancers, diabetes, premenstrual syndrome and transdermal transport |
| 07/28/2004 | CN1516587A Quinazoline derivatives capable of promoting release of parathyroid |
| 07/28/2004 | CN1515672A Human chemotactic factor beta-8, chemotactic factor beta-1 and macrophage inflammatory protein-4 |
| 07/28/2004 | CN1515571A Phenyl xanthine derivative |
| 07/28/2004 | CN1515548A Oxaminic acid used as thyroid gland receptor ligand and its derivative |
| 07/28/2004 | CN1515315A Stable composition containing epidermal growth factor and bletilla tuber extract |
| 07/28/2004 | CN1515286A Chinese medicinal herb extractive |
| 07/28/2004 | CN1515268A Tincture for curing freckle and melanotic nevus |
| 07/28/2004 | CN1515261A Topical medicine composite containing cholinergic drug or calcium channel paralyser |
| 07/28/2004 | CN1515256A Application of estrogen antagonist and estrogen excitent for inhibiting pathological disease |
| 07/28/2004 | CN1515242A Method and composition for whiting skin |
| 07/28/2004 | CN1159440C Mutants of Rb and p53 genes and uses thereof |
| 07/28/2004 | CN1159422C Preparation of additive for food, medicine anfd cosmetics and teplenishing linolic acid and gamma-linolenic acid |
| 07/28/2004 | CN1159313C Alkali-metal or alkali-earth metal salt of polyprotic acid delotadine and its medical composition |
| 07/28/2004 | CN1159038C Cream for healing skin burn and scald |
| 07/28/2004 | CN1159018C Honey Preparation to treat hand dermatitis caused by silk reeling |
| 07/28/2004 | CN1159013C Use of combination of vitamins for the treatment of pruritus and relating to itching and/or non-infective inflammatory disorders |
| 07/28/2004 | CN1159000C Buccal delivery system |
| 07/28/2004 | CN1158990C Skin-care face-beautying cream |
| 07/27/2004 | US6768026 Hormone inhibitors comprising carbocyclic ketones such as 3-(5-methoxyheptyl)-2-cyclohexenone used for prophylaxis of acne, alopecia, keloids or osteoarthritis |
| 07/27/2004 | US6767908 Treatment of cytokine mediated diseases such as arthritis. |
| 07/27/2004 | US6767736 Human ion channel protein and polynucleotides encoding the same |
| 07/27/2004 | US6767533 Use of a substance binding with the peripheral benzodiazepin receptor for treating skin stress |
| 07/22/2004 | WO2004061115A1 PROCESS FOR PRODUCING SOLUBLE β-GLUCAN HAVING IMMUNOLOGICAL FUNCTION AND USE THEREOF |
| 07/22/2004 | WO2004061073A2 Novel human proteins, polynucleotides encoding them and methods of using the same |
| 07/22/2004 | WO2004060875A1 Alkynyl-substituted azasugar derivative and drug containing the same as the active ingredient |
| 07/22/2004 | WO2004060364A1 Skin lightening composition |
| 07/22/2004 | WO2004060314A2 Treatment of skin wounds using polyenylphosphatidylcholine and alkanolamines |
| 07/22/2004 | WO2004039978A3 Human chondroosteomodulin (tig2), production, and use for the treatment or diagnosis of bone diseases, cartilage diseases, obesity, inflammatory diseases, and skin diseases |
| 07/22/2004 | WO2004037187A8 Metal-containing materials, compositions and methods |